Canan Bademlioğlu

After graduating from Middle East Technical University’s Department of Biology in 2000, Canan Bademlioğlu began her professional career in the Eczacıbaşı Group joint venture Eczacıbaşı-Baxter as Quality Assurance Specialist. Between 2001 and 2008, Bademlioğlu served as Product Manager and Senior Product Manager in the Renal Therapies Group of the same company. In 2008, she was appointed Marketing and Sales Manager in the Blood Therapies Group, and in 2014, Marketing and Sales Director responsible for all marketing, sales groups and commercial operations of Eczacıbaşı-Baxter. After Baxter’s decision to spin off Baxalta worldwide, she joined Baxalta as Global Marketing Director in 2015 and moved to London. In 2016, she was appointed General Manager of Eczacıbaşı-Baxalta. After the worldwide acquisition of Baxalta by Shire, she returned to the Eczacıbaşı Healthcare Division as the Strategic Planning and Business Development Director. Bademlioğlu served as the General Manager of EİP Eczacıbaşı İlaç Pazarlama from April 2017 to December 2018. She has been an Executive Board Member of EİP Eczacıbaşı İlaç Pazarlama since January 2019.

Canan Bademlioğlu is a supporter of measure to raise women’s role in business and strategic decision-making processes. She is a member of the Eczacıbaşı Diversity Inclusion Program and Women on Board certificate and mentoring program. Bademlioğlu also represents the Eczacıbaşı Healthcare Division in various sectoral organizations and is a member of the Board of Directors of several Eczacıbaşı Group companies.